---
title: "Shamken Spinners Ltd (SHAMKNSPIN) — Share Price, Financials & Analysis"
symbol: "SHAMKNSPIN"
company: "Shamken Spinners Ltd"
canonical: "https://tapetide.com/stocks/SHAMKNSPIN"
generated_at: "2026-10-13T11:00:46.733Z"
---

# Shamken Spinners Ltd (SHAMKNSPIN)

Canonical page: https://tapetide.com/stocks/SHAMKNSPIN

## Company

- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No

## About

Shamken Spinners Ltd. manufactures various yarns.

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 1% | 10% | 8% |

## Financial Statements

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 15m | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- |
| Sales | 63 | 52 | 28 | 0 | 0 |
| Expenses | 73 | 56 | 34 | 1 | 1 |
| Operating Profit | -10 | -4 | -6 | -1 | -1 |
| OPM % | -16 | -7 | -22 | — | — |
| Other Income | 1 | 2 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 15 | 12 | 12 | 11 | 11 |
| Profit before tax | -24 | -13 | -17 | -12 | -12 |
| Tax % | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -24 | -13 | -17 | -12 | -12 |
| EPS in Rs | -5.38 | -3 | -4 | -2.75 | -2.72 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 43 | 43 | 43 | 43 | 43 |
| Reserves | -84 | -97 | -113 | -138 | -139 |
| Borrowings | 230 | 233 | 236 | 242 | 231 |
| Other Liabilities | 7 | 5 | 2 | 1 | 1 |
| Total Liabilities | 197 | 184 | 169 | 148 | 137 |
| Fixed Assets | 176 | 165 | 153 | 135 | 124 |
| CWIP | 13 | 13 | 13 | 13 | 13 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 6 | 3 | 0 | 0 |
| Total Assets | 197 | 184 | 169 | 148 | 137 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1 | -3 | -6 | -1 | 5 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | 0 | 3 | 5 | 1 | -5 |
| Net Cash Flow | 1 | 0 | -1 | 0 | 0 |
| Free Cash Flow | 1 | -3 | -6 | -1 | 5 |
| CFO/OP | -14 | 83 | 98 | 94 | -996 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 7 | 2 | 9 | — | — |
| Inventory Days | 22 | 18 | 8 | — | — |
| Days Payable | 21 | 33 | 27 | — | — |
| Cash Conversion Cycle | 8 | -13 | -11 | — | — |
| Working Capital Days | -2 | 9 | 17 | — | — |
| ROCE % | — | -7 | -10 | — | -8 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 49.74 | Sell |
| EMA (10) | 50.36 | Sell |
| SMA (20) | 55.4 | Sell |
| EMA (20) | 52.81 | Sell |
| SMA (50) | 56.58 | Sell |
| EMA (50) | 59.26 | Sell |
| SMA (100) | 69.99 | Sell |
| EMA (100) | 78.82 | Sell |
| SMA (200) | 125.75 | Sell |
| EMA (200) | 127.92 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 40.36 | Neutral |
| MACD (12,26,9) | -2.94 | Sell |
| Stochastic (14,3,3) | 11.67 | Buy |
| ADX (14) | 24.61 | Neutral |
| Williams %R (14) | -87 | Buy |
| ATR (14) | 3.17 | High Volatility |
| ROC (12) | -13.82 | Sell |
| Stoch RSI (14) | 30.49 | Neutral |
| UO (7,14,28) | 43.97 | Neutral |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:00:46.733Z.
